Market Overview

Benzinga's Top Initiations

Related ARWR
Arrowhead Research Up Over 6% Following CNBC Comments
4 Biotech Stocks With Big Money Coming In
Related FMI
UPDATE: JMP Securities Initiates Coverage on Foundation Medicine on Clear First-Mover Advantage
Novel And Previously Reported Genomic Alterations Identified in Clinical Multiple Myeloma Cases Using FoundationOne Heme

Analysts at Piper Jaffray initiated coverage on shares of Arrowhead Research (NASDAQ: ARWR) with an “overweight” rating. The target price for Arrowhead Research is set to $12. Arrowhead Research's shares closed at $7.87 on Friday.

Analysts at Goldman Sachs initiated coverage on shares of Foundation Medicine (NASDAQ: FMI) with a “neutral” rating. The target price for Foundation Medicine is set to $33. Foundation Medicine's stock closed at $33.99 on Friday.

JP Morgan initiated coverage on shares of Premier (NASDAQ: PINC) with an “overweight” rating. The target price for Premier is set to $36. Premier's shares closed at $31.66 on Friday.

Morgan Stanley initiated coverage on shares of Ophthotech (NASDAQ: OPHT) with an “overweight” rating. The target price for Ophthotech is set to $56. Ophthotech's shares closed at $29.25 on Friday.

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Most Popular

Related Articles (ARWR + FMI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free